Smith Susan Laura - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 5, 2024, Smith Susan Laura's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Officer (SVP & CHIEF COMMERCIAL OFFICER), and currently has 33,918 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Data Source: SEC.
Smith Susan Laura - Insider Non-Derivative Transactions of YMAB Common Stock
Smith Susan Laura - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 6, 2024 | Sell -- (Common Stock) | 1682 | 16.55 | 33918 |
| Jan 19, 2024 | Acquisition -- (Common Stock) | 17800 | 0 | 35600 |
| Jan 18, 2023 | Acquisition -- (Common Stock) | 17800 | 0 | 17800 |